First Manhattan
NVRO

First Manhattan’s NEVRO CORP. NVRO Stock Holding History

First Manhattan’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-325,000
Closed -$26M – 1452
2018
Q2 		$26M Buy
325,000
+5,100
+2% +$423K 0.15% 104
2018
Q1 		$27.7M Buy
319,900
+93,500
+41% +$7.55M 0.16% 98
2017
Q4 		$15.6M Buy
+226,400
New +$18.1M 0.09% 153

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

First Manhattan's NVRO Position: Q3 2018 in Review

First Manhattan sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 325,000 shares — an estimated $26M sold.

First Manhattan first reported a position in NVRO in Q4 2017 and held it in 3 quarters. The position peaked at $27.7M in Q1 2018. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • First Manhattan reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • First Manhattan sold 325,000 NEVRO CORP. shares in Q3 2018, an estimated $26M.
  • First Manhattan first reported a position in NEVRO CORP. in Q4 2017 and held it in 3 quarters.
  • First Manhattan's NEVRO CORP. position peaked at $27.7M in Q1 2018.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on First Manhattan's 13F filing for Q3 2018, filed 15 Oct 2018.